ROC curves for significant fibrosis(A), advanced fibrosis (B) and... | Download Scientific Diagram
Hepamet
HEPAmet APK for Android Download
Frontiers | Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
Juan Turnes on Twitter: "@Dr_Ampuero presenta en #ILC2019 un algoritmo para identificar pacientes con esteatosis hepática y fibrosis avanzada basado en la combinación del Hepamet Fibrosis Score y el Fibroscan. Un nuevo
The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
Diagnostics | Free Full-Text | Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis - ScienceDirect
Hepamet
Hepamet
Hepamet
Diapositiva 1
HEPAmet by Francisco Duran Ortega
Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ...
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients - ScienceDirect
HEPAmet by Francisco Duran Ortega
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mix
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population | Annals of Hepatology
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
